Spine, joint replacement and now musculoskeletal tumour - Gleneagles Hospital Hong Kong launched its third specialty centre on 24 September to deal with complex malignant tumours that originate in bone or soft tissues such as the muscle and cartilage.
A multidisciplinary team is set up to provide proper diagnosis and treatment to this disease that is often neglected due to low public awareness.
Statistics from the Hong Kong Cancer Registry show that malignant musculoskeletal tumours are uncommon, with only about 250 new cases per year. As a result, public awareness is low and the risk of misdiagnosis is high and may worsen with lack of proper surgery and treatment.
Without proper image scanning and pathological examinations, musculoskeletal tumours can be easily misdiagnosed. A hastily planned surgery without concrete diagnosis also exposes the patient to unnecessary risks, including the possible spread of tumour cells during surgery. This could increase the complexity of subsequent surgeries, and may even require amputation due to lack of proper treatment or affect patients’ survival rates."
- Dr Timothy So, Director of the Musculoskeletal Tumour Centre and Honorary Consultant in Orthopaedics & Traumatology at Gleneagles Hong Kong Hospital
Related Stories
.png?sfvrsn=e4a6c77e_1)
Shaping our Future, Sustainably
How do sustainability and healthcare intersect to shape our future? This was the focus of our second HealthcareInsider leadership dialogue this year, themed "Shaping our Future, Sustainably," held on 1 August 2024.
Ukrainian Baby Hears for the First Time After 15 Months
In a heartwarming moment, Leia Dynnyk, a 15-month-old from Ukraine, experienced a miracle when she heard her mother’s voice for the first time after undergoing cochlear implant surgery at Acıbadem Kent Hospital in İzmir, Türkiye.
Transforming Cancer Care with Robotic Precision
Gleneagles HealthCity Chennai recently celebrated a significant milestone in clinical excellence, completing over 100 robotic-assisted cancer surgeries within a year.
Meet Our New Chairman
On 26 June, IHH welcomed veteran business leader and lawyer Tan Sri Dr Nik Norzrul Thani bin N Hassan Thani as Chairman and Independent Non-Executive Director of IHH Healthcare.
Union of Labs
On 1 July, nearly 300 laboratory staff from across the globe - both in-person and online -gathered for our inaugural IHH Labs Town Hall.
IHH Inaugural Risk and Compliance Forum 2024
IHH held its inaugural risk and compliance forum on 2 and 3 July 2024, under the theme of "Navigating Uncertainties. Forming Resilience. Seizing Opportunities”.